Controversy Debate 1: Is it justified to move from adjuvant to neo-adjuvant treatment? - Yes

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session Cancer of the Pancreas and Bile Ducts
Topics Cytotoxic agents
Pancreatic Cancer
Therapy
Biological therapy
Presenter Jordan D. Berlin
Authors J.D. Berlin
  • /US